Géraldine Cancel-Tassin

26PUBLICATIONS
317CO-AUTHORS
Predictive and prognostic markersMolecular targetsGene expression (incl. microarray and other genome-wide approaches)Cancer geneticsMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 10, 2026
Integrated signatures define mutational processes in prostate cancer.

|Sep 09, 2026
Recurrent mechanisms of biallelic epigenetic inactivation reveal new putative tumour suppressor genes in prostate cancer.

|Oct 02, 2025
Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry.

Kazzem Gheybi, Pamela X Y Soh, Jue Jiang

|May 30, 2024
A collaborative review of the microsatellite instability/deficient mismatch repair phenotype in patients with upper tract urothelial carcinoma.

Pierre-Etienne Gabriel, Géraldine Cancel-Tassin, François Audenet

|Nov 09, 2023
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.

Anqi Wang, Jiayi Shen, Alex A Rodriguez

|Jul 25, 2023
Prognostic value of programmed death ligand-1 and programmed death-1 expression in patients with upper tract urothelial carcinoma.

Luca Campedel, Eva Compérat, Géraldine Cancel-Tassin

Pageof 5

Frequent Collaborators

12 joint publications

Rosalind A Eeles

11 joint publications

Karina Dalsgaard Sorensen

10 joint publications

Mark N Brook

9 joint publications

Douglas F Easton